Orange Book product · Brand (NDA)

PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Brand (NDA)NDA 206056RX B BRAUN MEDICAL

View PIPERACILLIN SODIUM; TAZOBACTAM SODIUM family Open on FDA Orange Book

At a glance

Apr 03, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

None

Listed patents

Key dates

Approval
FDA approval date of this drug product.
Apr 03, 2025
1 yr 3 mo ago
Today

Pharmaceutical detail

Active ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Strength

EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL

Dosage form

POWDER

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 206056

Product number

002

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo